Hemophagocytic syndrome associated with leishmaniasis: case report

Secondary hemophagocytic syndrome (sHLH) is a hyperinflammatory reaction which manifests with fever, cytopenia and organ damage. possible causes of sHLH include leishmaniasis.  The article describes a clinical case of sHLH in patient with visceral leishmaniasis. A female 30 years old developed hectic daily fever up to 40 °C, pancytopenia, cytolytic syndrome, hyperferritin- and hypertriglyceridemia, immunoglobulin G to capsid antigens of the Epstein-Barr virus, enlarged liver and spleen a one and a half month after returning from Spain. based on the HLH-2004 and H-Score criteria, a sHLH was diagnosed, presumably associated with the Epstein-Barr virus. Immunosuppressive treatment with dexamethasone, cyclosporin-A and etoposide was started under the HLH-2004 program. Apyrexia, reduction of splenomegaly and resolution of cytolysis were achieved. The fever resumed 20 days after the start of chemotherapy, the spleen enlarged again, and therefore a diagnostic splenectomy was performed. Morphological analysis of the removed spleen revealed leishmania. After amphotericin-B therapy, the patient recovered.  Chemotherapy of sHLH led to a temporary improvement for a period sufficient to verify the diagnosis and conducting of successful treatment.

1. Maschan M.A. Molecular genetic diagnosis and differential therapy of histiocytic proliferative diseases in children. Dis. . doctor of medical sciences. Moscow, 2011. 62 p. (In Russ.).

2. Kostik M.M., Dubko M.F., Masalova V.V. et al. Modern approaches to the diagnosis and treatment of the syndrome of macrophage activation in children with rheumatic diseases. Sovremennaya revmatologiya = Modern Rheumatology 2015;9(1):55-9. [(In Russ.).

3. Potapenko V.G., Klimovich A.V., Pervakova M.Yu. et al. Secondary hemophagocytic syndrome in adult patients. Study of 91 patients. Onkogematologiya = Oncohematology 2020; 15(4):52-64. (In Russ.). DOI: 10.17650/1818-8346-2020-15-4-52-64

4. Li J., Wang Q., Zheng W. et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 2014;93(2):100-5. DOI: 10.1097/MD.0000000000000022

5. La Rosee P., Horne A., Hines M. et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019;133(23):2465-77. DOI: 10.1182/blood.2018894618

6. Henter J.I., Horne A., Arico M. et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lympho-histiocytosis. Pediatr Blood Cancer 2007;48(2):124-31. DOI: 10.1002/pbc.21039

7. Fardet L., Galicier L., Lambotte O. et al. Development and validation of the HScore, a Score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014;66(9):2613-20. DOI: 10.1002/art.38690

8. Medical parasitology and parasitic diseases. Protozooses and helminthiases: a textbook. Eds.: A.B. Khodzhayan, S.S. Kozlov, M.V. Golubeva. Moscow: GEOTAR-Media, 2016. 446 p. (In Russ.).

9. Roy S., Gupta P., Palit S. et al. The role of PD-1 in regulation of macrophage apoptosis and its subversion by Leishmania donovani. Clin Transl Immunology 2017;6(5):e137. DOI: 10.1038/cti.2017.12

10. Gupta P., Srivastav S., Saha S. et al. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of в-catenin and FOXO-1. Cell Death Differ 2016;23(11):1815-26. DOI: 10.1038/cdd.2016.101

11. Reiner S.L., Zheng S., Wang Z.E. et al. Leishmania promastigotes evade interleukin 12 (IL-12) induction bymacrophages and stimulate a broad range of cytokines from CD4C T cells during initiation of infection. J Exp Med 1994;179(2):447-56. DOI: 10.1084/jem.179.2.447

12. Carrera L., Gazzinelli R.T., Badolato R. et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996;183(2):515-26. DOI: 10.1084/jem.183.2.515

13. Scianimanico S., Desrosiers M., Dermine J.F. et al. Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promasti-gotes. Cell Microbiol 1999;1(1):19-32. DOI: 10.1046/j.1462-5822.1999.00002.x

14. Courret N., Prina E., Mougneau E. et al. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur J Immunol 1999;29(3):762-73. DOI: 10.1002/(SICI)1521-4141(199903)29

15. Chakraborty D., Banerjee S., Sen A. et al. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 2005;175(5):3214-24. DOI: 10.4049/jimmunol.175.5.3214

16. Human parasitic diseases (protozooses and helminthiases): physicians guide. Eds.: V.P. Sergiev, Yu.V. Lobzin, S.S. Kozlov. Saint-Petersburg: Foliant, 2016. 640 p. (In Russ.).

17. Cruz I., Chicharro C., Nieto J. et al. Comparison of new diagnostic tools for management of pediatric mediterranean visceral leishmaniasis. J Clin Microbiol 2006;44(7):2343-7. DOI: 10.1128/JCM.02297-05

18. Тропические болезни: учебник. Под ред. Е.П. Шуваловой. СПб., 2004. 703 с. [Tropical diseases: a textbook. Ed.: E.P. Shuvalovа. Saint-Petersburg, 2004. 703 p. (In Russ.)].

19. Salam M.A., Khan M.G., Bhaskar K.R. et al. Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis. J Clin Microbiol 2012;50(3):837-40. DOI: 10.1128/JCM.05067-11

20. Sharma M.C., Gupta A.K., Das V.N. et al. Leishmania donovani in blood smears of asymptomatic persons. Acta Trop 2000;76(2):195-6. DOI: 10.1016/s0001-706x(00)00068-1

21. Bekhtereva M.K., Kozlov S.S., Komarova A.M. et al. Visceral leishmaniasis in a child: difficulties in diagnosis and treatment. Infektologiya = Journal of Infectology 2019;1(3):118-25. (In Russ.).

22. Farrar J., Hotez P.J., Junghanss T. et al. Manson's tropical diseases. Elsevier, 2013. 23 p.

23. Daher E.F., Lima L.L., Vieira A.P. et al. Hemophagocytic syndrome in children with visceral leishmaniasis. Pediatr Infect Dis J 2015;34(12):1311-4. DOI: 10.1097/INF.0000000000000916

24. Clinical evaluation of laboratory tests. Ed.: N.U. Tits. Moscow, 1986. 480 p. (In Russ.).

25. Altuglu I., Bozkurt H., Samlioglu P., Zeytinoglu A. Evaluation of three different assays for the assessment of Epstein-Barr Virus immunological status. New Microbiol 2007;30(4):393-8.

26. Karadag Geijgel S., Ersoy A., Sevinir B.B. et al. Epstein-Barr virus enfeksiyonlarinin tanisinda PCR sonujlarinin degerlendirilmesi [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections]. Mikrobiyol Bul 2012;46(4):594-606.

27. Idris M., Farid J., Gul N. Morphology of bone marrow in visceral leishmaniasis. J Ayub Med Coll Abbottabad 2018;30(3):342-4.

28. Brito-Zeron P., Kostov B., Moral-Moral P. et al. Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis. Mayo Clin Proc Innov Qual Outcome 2018;2(3):267-76. DOI: 10.1016/j.mayocpiqo.2018.06.006

29. Arca M., Fardet L., Galicier L. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 2015;168(1):63-8. DOI: 10.1111/bjh.13102

30. Jing-Shi W., Yi-Ni W., Lin W., Zhao W. Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause. Ann Hematol 2015;94(5):753-60. DOI: 10.1007/s00277-014-2276-9

31. Lyngdoh E., Jain S.C., Barua P. Splenectomy in treatment of drug-resistant Kala-azar. J Ind Med Assoc 1971;57:458-61.

32. Troya J., Casquero A., Mufliz G. et al. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis. Parasitology 2007; 134(Pt 5):621-4. DOI: 10.1017/S0031182006002058

33. Dutra R.A., Dutra L.F., Reis M. de O., Lambert R.C. Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report. Rev Soc Bras Med Trop 2012;45(1):130-1. DOI: 10.1590/s0037-86822012000100027

34. Reinaldo L.G.C., Araujo Junior R.J.C., Diniz T.M. et al. Recurrent kala-azar: report of two cured cases after total splenectomy. Rev Inst Med Trop Sao Paulo 2020; 62:e31. DOI: 10.1590/s1678-9946202062031